Author
Listed:
- Jaime S. Rosa Duque
(The University of Hong Kong)
- Xiwei Wang
(The University of Hong Kong)
- Daniel Leung
(The University of Hong Kong)
- Samuel M. S. Cheng
(The University of Hong Kong)
- Carolyn A. Cohen
(The University of Hong Kong
The University of Hong Kong)
- Xiaofeng Mu
(The University of Hong Kong)
- Asmaa Hachim
(The University of Hong Kong
The University of Hong Kong
University of Oxford)
- Yanmei Zhang
(The University of Hong Kong)
- Sau Man Chan
(The University of Hong Kong)
- Sara Chaothai
(The University of Hong Kong)
- Kelvin K. H. Kwan
(The University of Hong Kong)
- Karl C. K. Chan
(The University of Hong Kong)
- John K. C. Li
(The University of Hong Kong)
- Leo L. H. Luk
(The University of Hong Kong)
- Leo C. H. Tsang
(The University of Hong Kong)
- Wilfred H. S. Wong
(The University of Hong Kong)
- Cheuk Hei Cheang
(The University of Hong Kong)
- Timothy K. Hung
(The University of Hong Kong)
- Jennifer H. Y. Lam
(The University of Hong Kong)
- Gilbert T. Chua
(The University of Hong Kong)
- Winnie W. Y. Tso
(The University of Hong Kong
The University of Hong Kong)
- Patrick Ip
(The University of Hong Kong)
- Masashi Mori
(Ishikawa Prefectural University)
- Niloufar Kavian
(The University of Hong Kong
The University of Hong Kong
IRCCS, Humanitas Research Hospital)
- Wing Hang Leung
(The University of Hong Kong)
- Sophie Valkenburg
(The University of Hong Kong
The University of Hong Kong
Peter Doherty Institute for Infection and Immunity, University of Melbourne)
- Malik Peiris
(The University of Hong Kong
Centre for Immunology and Infection)
- Wenwei Tu
(The University of Hong Kong)
- Yu Lung Lau
(The University of Hong Kong)
Abstract
No abstract is available for this item.
Suggested Citation
Jaime S. Rosa Duque & Xiwei Wang & Daniel Leung & Samuel M. S. Cheng & Carolyn A. Cohen & Xiaofeng Mu & Asmaa Hachim & Yanmei Zhang & Sau Man Chan & Sara Chaothai & Kelvin K. H. Kwan & Karl C. K. Chan, 2022.
"Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents,"
Nature Communications, Nature, vol. 13(1), pages 1-1, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32337-6
DOI: 10.1038/s41467-022-32337-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32337-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.